MedTrace Logo

The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine

NCT02657031 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2017-12-11

Study results available
· View outcomes & findings →

Summary

This study compares the efficacy of low dose Ketamine versus Compazine for the control of headache in patients presenting to the Emergency Department.

Conditions

Interventions

DRUG

Prochlorperazine

prochlorperazine 10 mg IV

DRUG

Ketamine

Ketamine 0.3 mg/kg IV

DRUG

Diphenhydramine

Diphenhydromine 25 mg IV

DRUG

Ondansetron

Ondansetron 4 mg IV

DRUG

Normal Saline

Normal Saline 500 cc IV Bolus

Sponsors & Collaborators

  • University Medical Center of Southern Nevada

    lead OTHER

Principal Investigators

  • Joseph A Zitek, MD · Unviersity of Nevada School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-17
Primary Completion
2017-03-21
Completion
2017-03-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02657031 on ClinicalTrials.gov